REGN

Regeneron Pharmaceuticals, Inc.NASDAQ

811.21 USDT+0.81%Bybit perpetual · refreshed every 30s

24h value$10.7KOpen interest$29.2KFunding0.0000%regeneron.com ↗

Key filings

Earnings, material events (8-K), quarterly and annual reports, ownership reports

2026-10-068-KMaterial event report · Material agreement, Earnings release, Other eventsSource ↗
2026-09-308-KMaterial event report · Officer/director changeSource ↗
2026-07-3010-QQuarterly reportSource ↗
2026-07-308-KMaterial event report · Earnings releaseSource ↗
2026-07-068-KMaterial event report · Earnings releaseSource ↗
2026-06-178-KMaterial event report · Shareholder vote resultsSource ↗
2026-04-30SCHEDULE 13G5%+ ownership (passive)Source ↗
2026-04-2910-QQuarterly reportSource ↗
2026-04-298-KMaterial event report · Earnings releaseSource ↗
2026-04-24DEF 14AProxy statementSource ↗
2026-04-088-KMaterial event report · Earnings releaseSource ↗
2026-03-27SCHEDULE 13G/A5%+ ownership (passive) (Amended)Source ↗
2026-02-0410-KAnnual reportSource ↗
2026-01-308-KMaterial event report · Earnings releaseSource ↗
2026-01-128-KMaterial event report · Earnings release, Reg FD disclosureSource ↗

Filings are in English. Form and item labels are only a classification to help you navigate and do not interpret the filing.

Stock transactions by officers and major holders (Form 4) and notices of proposed sale (Form 144)